HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$0.15
Day range
$0.14 - $0.15
Year range
$0.14 - $21.56
Market cap
1.95M USD
Avg Volume
1.82M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.98M | -25.92% |
Net income | -5.88M | 25.98% |
Net profit margin | — | — |
Earnings per share | -1.67 | 96.91% |
EBITDA | -5.93M | 26.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.07M | -61.60% |
Total assets | 14.92M | -48.39% |
Total liabilities | 10.46M | -17.39% |
Total equity | 4.46M | — |
Shares outstanding | 9.42M | — |
Price to book | 0.14 | — |
Return on assets | -92.53% | — |
Return on capital | -135.64% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.88M | 25.98% |
Cash from operations | -6.15M | -28.11% |
Cash from investing | — | — |
Cash from financing | 3.97M | 725.16% |
Net change in cash | -2.18M | 49.47% |
Free cash flow | -3.97M | -108.98% |
About
Founded
2016
Headquarters
Website
Employees
40